LEN vs OVID · rev $6.83B vs rev $733.0K
LEN (LEN) versus Ovid Therapeutics Inc (OVID) — a side-by-side from cached financials, not a winner call.
LEN (LEN) common stock.
Ovid Therapeutics Inc (OVID) is a biotechnology company listed on US.
Latest reported LEN revenue for 2020-11-30 was $6.83B. Net income was $882.8M. Revenue was down 2.1% from 2019-11-30 to 2020-11-30. LEN currently screens at market cap $0.
Latest reported OVID revenue for 2026-06-30 was $733.0K. Net income was -$32.0M. OVID currently screens at market cap $23.5M.
LEN currently screens at market cap $0. OVID currently screens at market cap $23.5M.
Not investment advice. Open the LEN and OVID stock pages for the full models.
Not investment advice.